Clinical features of 10 prostate cancer patients and numbers of CTC detecteda.
| Patient number | Clinical stageb | Risk classificationc | CTC number |
|---|---|---|---|
| 1 | T3aN0M0 | High | 2 |
| 2 | T3aN0M0 | High | 2 |
| 3 | T3bN1M0 | High | 3 |
| 4 | T2cN0M0 | High | 0 |
| 5 | T3bN0M0 | High | 0 |
| 6 | T3aN1M0 | High | 1 |
| 7 | T3aN0M0 | High | 1 |
| 8 | T2aN0M0 | Low | 0 |
| 9 | T2bN0M0 | Intermediate | 1 |
| 10 | T2cN0M0 | High | 2 |
a
CTC: Circulating Tumour Cell.
b
Tumour Node Metastasis (TNM) classification, International Union Against Cancer, 8th edition.
c
2017 European Association of Urology risk groups for biochemical recurrence.